• 人生就是搏

    Reliable Quality

    Affordable Innovation

    Name Indication Clinical Trial Phase Study Title
    HLX01
    DLBCL
    Phase III

    Clinical Study to Compare the Efficacy and Safety of Rituximab Biosimilar HLX01 in Combination with CHOP and Rituximab in Combination with CHOP

    HLX01
    RA
    Phase I/II

    A Phase 1/2 Study to Evaluate the PK, PD, Safety, and Efficacy between HLX01 and Rituximab in Patients with Rheumatoid Arthritis

    HLX01
    RA
    Phase III

    A Phase III Study of Safety and Efficacy of HLX01+MTX in Patients with Moderate to Severe Active Rheumatoid Arthritis